Syfovre is not yet indicated for early or intermediate stages of dry macular degeneration. Syfovre is currently the only FDA-approved medication to treat geographic atrophy secondary to advanced dry macular degeneration.
Syfovre is not yet indicated for early or intermediate stages of dry macular degeneration. Syfovre is currently the only FDA-approved medication to treat geographic atrophy secondary to advanced dry macular degeneration.